PFE · 10-Q · 2026Q2 · Full report

Supply Chain Constraints

PFIZER INC · 2026-08-04 · Importance 7 · Surprise 6

Pfizer reported no significant supply-chain disruption during the first six months of 2026 through the filing date. Its global manufacturing sites continued to operate at or near normal levels. The company does not anticipate raw-material availability having a significant impact on 2026 operations, but is monitoring potential disruptions related to geopolitical and trade negotiations that could affect costs. Pfizer continues to identify potential delays, disruptions and shortages as risks, including those associated with recalls and natural or man-made disasters.